HFS
SNOA icon

HBC Financial Services’s Sonoma Pharmaceuticals SNOA Stock Holding History

HBC Financial Services’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Hold
0
– – – 189
2024
Q2 		– Hold
0
– – – 176
2024
Q1 		– Hold
0
– – – 183
2023
Q4 		– Hold
0
– – – 201
2023
Q3 		– Hold
0
– – – 194
2023
Q2 		– Hold
0
– – – 207
2023
Q1 		– Hold
0
– – – 196
2022
Q4 		– Sell
-10
Closed -$17K – 181
2022
Q3 		$17K Sell
10
-8
-44% -$469 0.01% 92
2022
Q2 		$34K Hold
18
– – 0.03% 74
2022
Q1 		$39K Hold
18
– – 0.03% 68
2021
Q4 		$54K Buy
+18
New +$1.92K 0.03% 57
2021
Q3 		– Hold
0
– – – 192
2021
Q2 		– Hold
0
– – – 197
2021
Q1 		– Hold
0
– – – 195
2020
Q4 		– Hold
0
– – – 188
2020
Q3 		– Hold
0
– – – 192
2020
Q2 		– Hold
0
– – – 170
2020
Q1 		– Hold
0
– – – 166
2019
Q4 		– Hold
0
– – – 169

Other funds holding SNOA

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return

HBC Financial Services's SNOA Position: Q3 2024 in Review

HBC Financial Services held its Sonoma Pharmaceuticals (SNOA) position steady in Q3 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #189.

HBC Financial Services first reported a position in SNOA in Q4 2021 and has held it in 4 quarters since. The position peaked at $54K in Q4 2021. 14 funds tracked by Wall St. Rank hold SNOA as of Q3 2024.

  • HBC Financial Services held 0 shares of Sonoma Pharmaceuticals worth $0 as of Q3 2024.
  • HBC Financial Services left its Sonoma Pharmaceuticals share count unchanged in Q3 2024.
  • Sonoma Pharmaceuticals made up ﹤0.01% of HBC Financial Services's portfolio in Q3 2024, its #189 holding.
  • HBC Financial Services first reported a position in Sonoma Pharmaceuticals in Q4 2021 and has held it in 4 quarters since.
  • HBC Financial Services's Sonoma Pharmaceuticals position peaked at $54K in Q4 2021.
  • 14 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q3 2024.

Based on HBC Financial Services's 13F filing for Q3 2024, filed 7 Nov 2024.